Carlo Antozzi

8.5k total citations
138 papers, 4.3k citations indexed

About

Carlo Antozzi is a scholar working on Neurology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Carlo Antozzi has authored 138 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Neurology, 27 papers in Molecular Biology and 18 papers in Infectious Diseases. Recurrent topics in Carlo Antozzi's work include Myasthenia Gravis and Thymoma (77 papers), Peripheral Neuropathies and Disorders (41 papers) and Parkinson's Disease and Spinal Disorders (22 papers). Carlo Antozzi is often cited by papers focused on Myasthenia Gravis and Thymoma (77 papers), Peripheral Neuropathies and Disorders (41 papers) and Parkinson's Disease and Spinal Disorders (22 papers). Carlo Antozzi collaborates with scholars based in Italy, United States and United Kingdom. Carlo Antozzi's co-authors include Renato Mantegazza, F. Cornelio, Fulvio Baggi, Massimo Zeviani, Paolo Confalonieri, Pia Bernasconi, Lorenzo Maggi, Stefano DiDonato, Lucía Morandi and Paola Cavalcante and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Carlo Antozzi

134 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlo Antozzi Italy 37 2.2k 1.4k 640 513 396 138 4.3k
Oluf Andersen Sweden 39 1.5k 0.7× 2.0k 1.4× 400 0.6× 211 0.4× 303 0.8× 135 5.9k
Saeed Bohlega Saudi Arabia 34 1.2k 0.5× 1.3k 0.9× 195 0.3× 111 0.2× 876 2.2× 130 3.8k
Audrey S. Penn United States 30 3.3k 1.6× 989 0.7× 214 0.3× 605 1.2× 470 1.2× 54 4.8k
Brendan McLean United Kingdom 23 499 0.2× 421 0.3× 169 0.3× 262 0.5× 211 0.5× 60 2.2k
Michael Beck Germany 59 606 0.3× 1.6k 1.2× 262 0.4× 114 0.2× 125 0.3× 213 12.2k
Robert J. Hopkin United States 40 632 0.3× 1.5k 1.1× 153 0.2× 72 0.1× 134 0.3× 189 5.8k
Chongbo Zhao China 26 1.3k 0.6× 515 0.4× 93 0.1× 274 0.5× 202 0.5× 173 2.3k
Catherine Lacroix France 30 755 0.4× 649 0.5× 80 0.1× 587 1.1× 492 1.2× 56 2.8k
Janbernd Kirschner Germany 37 585 0.3× 2.2k 1.6× 205 0.3× 144 0.3× 595 1.5× 182 4.1k
Paige Kaplan United States 42 191 0.1× 1.6k 1.2× 665 1.0× 100 0.2× 185 0.5× 135 5.7k

Countries citing papers authored by Carlo Antozzi

Since Specialization
Citations

This map shows the geographic impact of Carlo Antozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Antozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Antozzi more than expected).

Fields of papers citing papers by Carlo Antozzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Antozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Antozzi. The network helps show where Carlo Antozzi may publish in the future.

Co-authorship network of co-authors of Carlo Antozzi

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Antozzi. A scholar is included among the top collaborators of Carlo Antozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Antozzi. Carlo Antozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rinaldi, Elena, Rita Frangiamore, Fiammetta Vanoli, et al.. (2025). Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis. Neurology Neuroimmunology & Neuroinflammation. 12(5). e200455–e200455. 2 indexed citations
2.
Fornari, Arianna, Matilde Leonardi, Alberto Raggi, et al.. (2025). Anxiety, Depression, and Expanded Disability Status Scale Independently Predict the Perception of Disability in Persons With Multiple Sclerosis: A Cross‐Sectional Study. Behavioural Neurology. 2025(1). 2744955–2744955. 1 indexed citations
3.
Canavero, Isabella, Nicola Rifino, Carlo Antozzi, et al.. (2025). Blurred by a “Puff of Smoke”—A Case-Based Review on the Challenging Recognition of Coexisting CNS Demyelinating Disease and Moyamoya Angiopathy. International Journal of Molecular Sciences. 26(11). 5030–5030.
4.
Antozzi, Carlo, Rita Frangiamore, Elena Rinaldi, et al.. (2025). Efgartigimod improves non-AChR generalized Myasthenia Gravis: a real world experience. Neurological Sciences. 46(7). 3271–3279. 1 indexed citations
5.
Raggi, Alberto, Arianna Fornari, Marco Leonardi, et al.. (2024). 502P Cognitive functioning in myasthenia gravis: an Italian cohort study. Neuromuscular Disorders. 43. 104441.635–104441.635. 1 indexed citations
6.
Antozzi, Carlo, Jeffrey T. Guptill, Vera Bril, et al.. (2023). Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis. Neurology. 102(2). e207937–e207937. 30 indexed citations
7.
Evoli, Amelia, Giovanni Antonini, Carlo Antozzi, et al.. (2019). Italian recommendations for the diagnosis and treatment of myasthenia gravis. Neurological Sciences. 40(6). 1111–1124. 47 indexed citations
8.
Mantegazza, Renato & Carlo Antozzi. (2018). When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies. Therapeutic Advances in Neurological Disorders. 11. 475970702–475970702. 155 indexed citations
9.
Brambilla, Laura, Davide Rossi Sebastiano, Domenico Aquino, et al.. (2016). Early effect of dalfampridine in patients with MS: A multi-instrumental approach to better investigate responsiveness. Journal of the Neurological Sciences. 368. 402–407. 16 indexed citations
10.
Cordiglieri, Chiara, Fulvio Baggi, Pia Bernasconi, et al.. (2016). Identification of a gene expression signature in peripheral blood of multiple sclerosis patients treated with disease-modifying therapies. Clinical Immunology. 173. 133–146. 9 indexed citations
11.
Citterio, Antonietta, Ettore Beghi, Andrea Millul, et al.. (2009). Risk factors for tumor occurrence in patients with myasthenia gravis. Journal of Neurology. 256(8). 1221–1227. 26 indexed citations
12.
Raggi, Alberto, Matilde Leonardi, Carlo Antozzi, et al.. (2009). Concordance between severity of disease, disability and health-related quality of life in Myasthenia gravis. Neurological Sciences. 31(1). 41–45. 45 indexed citations
13.
Antozzi, Carlo, Carolina Frassoni, A. Vincent, et al.. (2005). Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia. Neurology. 64(7). 1290–1293. 19 indexed citations
14.
Baggi, Fulvio, Andrea Annoni, Monica Milani, et al.. (2004). Breakdown of Tolerance to a Self-Peptide of Acetylcholine Receptor α-Subunit Induces Experimental Myasthenia Gravis in Rats. The Journal of Immunology. 172(4). 2697–2703. 67 indexed citations
15.
Baggi, Fulvio, Andrea Annoni, Renato Longhi, et al.. (2003). Immunization with Rat‐, but Not Torpedo‐Derived 97–116 Peptide of the AChR α‐Subunit Induces Experimental Myasthenia Gravis in Lewis Rat. Annals of the New York Academy of Sciences. 998(1). 391–394. 6 indexed citations
16.
Baggi, Fulvio, Andrea Annoni, Renato Longhi, et al.. (2003). Effect on T Cell Recognition and Immunogenicity of Alanine‐Substituted Peptides Corresponding to 97–116 Sequence of the Rat AChR α‐Subunit. Annals of the New York Academy of Sciences. 998(1). 395–398. 4 indexed citations
17.
Antozzi, Carlo, Franco Carrara, Ludovico D’Incerti, et al.. (2001). A novel mtDNA mutation in the ND5 subunit of complex I in two MELAS patients. Annals of Neurology. 49(1). 106–110. 91 indexed citations
18.
Baggi, Fulvio, Francesca Andreetta, Monica Milani, et al.. (1999). Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravis. Journal of Clinical Investigation. 104(9). 1287–1295. 40 indexed citations
19.
Zeviani, Massimo & Carlo Antozzi. (1992). Defects of Mitochondrial DNA. Brain Pathology. 2(2). 121–132. 34 indexed citations
20.
Zeviani, Massimo, Cinzia Gellera, Carlo Antozzi, et al.. (1991). Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNALeu(UUR). The Lancet. 338(8760). 143–147. 300 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oluf Andersen Breakdown of academic impact, for papers by Saeed Bohlega Breakdown of academic impact, for papers by Audrey S. Penn Breakdown of academic impact, for papers by Brendan McLean Breakdown of academic impact, for papers by Michael Beck Breakdown of academic impact, for papers by Robert J. Hopkin Breakdown of academic impact, for papers by Chongbo Zhao Breakdown of academic impact, for papers by Catherine Lacroix Breakdown of academic impact, for papers by Janbernd Kirschner Breakdown of academic impact, for papers by Paige Kaplan
Rankless by CCL
2026